Sertraline Tablets

SOL #: SPE2D2-26-D-0012Award Notice

Overview

Buyer

DEPT OF DEFENSE
Defense Logistics Agency
DLA TROOP SUPPORT
PHILADELPHIA, PA, 19111, United States

Place of Performance

Hauppauge, NY

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

Drugs And Biologicals (6505)

Set Aside

No set aside specified

Timeline

1
Posted
Apr 21, 2026

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Defense Logistics Agency (DLA) Troop Support has awarded contract SPE2D2-26-D-0012 for Sertraline Tablets to pharmaceutical prime vendors. This Unrestricted award, valued at an estimated $22,510,720.70 over a five-year period, ensures the supply of various strengths and counts of Sertraline. The award notice was published on April 21, 2026.

Scope of Work

This contract covers the procurement of Sertraline tablets in multiple dosages and bottle configurations:

  • Sertraline 25MG Tablets: 30, 90, 180, 500 count bottles
  • Sertraline 50MG Tablets: 30, 90, 100, 180, 500 count bottles
  • Sertraline 100MG Tablets: 30, 60, 90, 100, 180, 500 count bottles Quantities are specified for a Base Year and four Option Years.

Contract Details

  • Contract Number: SPE2D2-26-D-0012
  • Type: Requirements-type contract (implied)
  • Duration: 5-year period (Base Year + 4 Option Years)
  • Estimated Value: $22,510,720.70
  • Set-Aside: Unrestricted
  • NAICS Code: 325412 (Pharmaceutical Preparation Manufacturing)
  • Size Standard: 1300 employees
  • Award Date: April 21, 2026

Background

This award follows solicitation SPE2D2-26-R-0002, which was issued on November 10, 2025, with offers due by December 17, 2025. The solicitation incorporated various FAR clauses related to commercial products and services.

Additional Notes

Current Pharmaceutical Prime Vendors listed in Appendix A include AmerisourceBergen Drug Corporation, Cardinal Health Inc., DMS Pharmaceutical Group, Inc., and McKesson Corp. The place of performance is Hauppauge, NY.

People

Points of Contact

Christopher NewmanPRIMARY
Jason WraySECONDARY

Files

Files

Download

Versions

Version 1Viewing
Award Notice
Posted: Apr 21, 2026
Sertraline Tablets | GovScope